INDUSTRY SRCE CONSULTING (INSO) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 4 115 sessions, March 27, 2024 to March 27, 2025
- Largest daily move
- -95% close of November 29, 2024
- 1-year change
- -95.7% closing prices, March 27, 2024 to March 27, 2025
- 5-year change
- -99.7% closing prices, March 27, 2020 to March 27, 2025
Company Description
INDUSTRY SRCE CONSULTING (OTC: INSO) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $10.9K.
INSO has declined 95.7% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for INSO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
INDUSTRY SRCE CONSULTING (INSO) closed at $0.0001 on March 27, 2025. Over the past 12 months, the price has lost 95.7%.
INSO Metrics & Rankings
Price returns through March 27, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
INDUSTRY SRCE CONSULTING has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition. View all INSO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
INSO Company Profile & Sector Positioning
INDUSTRY SRCE CONSULTING (INSO) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing INSO often look at related companies in the same sector, including ITEM 9 LABS CORP (INLB), PRIORITY AVIATION INC (PJET), MJARDIN GROUP INC (MJARF), HALO COLLECTIVE INC (HCANF), and AVIVAGEN INC ORD (VIVXF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate INSO's relative position within its industry.